Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on June 2, 2026

6 hours ago

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Indeterminate GlobeNewswire

6 hours ago

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

Indeterminate GlobeNewswire

6 hours ago

ASHA: This Summer, Protect Your Hearing Without Missing the Fun

Indeterminate GlobeNewswire

6 hours ago

Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing

Indeterminate GlobeNewswire

6 hours ago

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Indeterminate GlobeNewswire

6 hours ago

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure

Indeterminate GlobeNewswire

6 hours ago

Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome

Indeterminate GlobeNewswire

6 hours ago

Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

6 hours ago

TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens

Indeterminate GlobeNewswire

6 hours ago

INVO Fertility Announces Fiscal Year 2025 Financial Results

Indeterminate GlobeNewswire

6 hours ago

Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout

Indeterminate GlobeNewswire

6 hours ago

Inventiva annonce une optimisation globale de sa structure financière, comprenant un financement obligataire et une offre d'American Depositary Shares, en prévision de la publication attendue des résultats de l'essai de phase 3

Indeterminate GlobeNewswire

6 hours ago

Celcuity’s Gedatolisib Combination Regimens Doubled the Likelihood of Survival without Disease Progression or Death Compared to Alpelisib plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial in Patients with HR+/HER2-…

Indeterminate GlobeNewswire

7 hours ago

U.S. District Court Issues Decision Regarding CINVANTI® Patents

Indeterminate GlobeNewswire

7 hours ago

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics

Indeterminate GlobeNewswire

7 hours ago

Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health

Indeterminate GlobeNewswire

7 hours ago

Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer

Indeterminate GlobeNewswire

7 hours ago

SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041

Indeterminate GlobeNewswire

7 hours ago

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

Indeterminate GlobeNewswire

7 hours ago

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

Indeterminate GlobeNewswire